Evidence map›Paper›PMID 37694680›Full record

ArticleEMBO reports2023

CHK1-CDC25A-CDK1 regulate cell cycle progression and protect genome integrity in early mouse embryos.

Lucie Knoblochova, Tomas Duricek, Michaela Vaskovicova, Chrysoula Zorzompokou, Diana Rayova, Ivana Ferencova, Vladimir Baran, Richard M Schultz, Eva R Hoffmann, David Drutovic

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. A concise guide to fluorescent cell cycle reporters for live-cell imaging.Frontiers in cell and developmental biology · 2025
    Review
  15. Article
  16. Collective effects of cell cleavage dynamics.Frontiers in cell and developmental biology · 2024
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Lucie KnoblochovaInstitute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.ORCID 0000-0001-9844-7086
Tomas DuricekInstitute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.ORCID 0000-0001-7058-0950
Michaela VaskovicovaInstitute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.ORCID 0000-0003-4928-5732
Chrysoula ZorzompokouInstitute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.ORCID 0000-0002-7821-6261
Diana RayovaInstitute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.ORCID 0000-0002-6420-6724
Ivana FerencovaInstitute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.ORCID 0000-0002-8300-7229
Vladimir BaranInstitute of Animal Physiology, Centre of Biosciences, Slovak Academy of Sciences, Kosice, Slovakia.ORCID 0000-0002-1686-2145
Richard M SchultzDepartment of Biology, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-5923-6825
Eva R HoffmannDNRF Center for Chromosome Stability, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-2588-0652
David DrutovicInstitute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.ORCID 0000-0001-7099-3042
Czech Academy of Sciences, Institute of Animal Physiology and Genetics · CZCharles University · CZSlovak Academy of Sciences · SKUniversity of Copenhagen · DKUniversity of Pennsylvania · US

Funding

Danmarks Frie Forskningsfond (DFF) 0134-00299BEC ¦ European Research Council (ERC) 724718Grantová Agentura České Republiky (GAČR) 20-27742SGrantová Agentura, Univerzita Karlova (GA UK) 1402217Laege Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat (LAEGE SOFUS CARL EMIL FRIIS OG HUSTRU OLGA DORIS FRIIS LEGAT)Vedecká Grantová Agentúra MŠVVaŠ SR a SAV (VEGA) 2/0072/19
6 · The paper itself

Abstract

After fertilization, remodeling of the oocyte and sperm genomes is essential to convert these highly differentiated and transcriptionally quiescent cells into early cleavage-stage blastomeres that are transcriptionally active and totipotent. This developmental transition is accompanied by cell cycle adaptation, such as lengthening or shortening of the gap phases G1 and G2. However, regulation of these cell cycle changes is poorly understood, especially in mammals. Checkpoint kinase 1 (CHK1) is a protein kinase that regulates cell cycle progression in somatic cells. Here, we show that CHK1 regulates cell cycle progression in early mouse embryos by restraining CDK1 kinase activity due to CDC25A phosphatase degradation. CHK1 kinase also ensures the long G2 phase needed for genome activation and reprogramming gene expression in two-cell stage mouse embryos. Finally, Chk1 depletion leads to DNA damage and chromosome segregation errors that result in aneuploidy and infertility.

Indexed as

cdc25 PhosphatasesCDC2 Protein KinaseCell CycleCheckpoint Kinase 1Embryo, MammalianGenomic InstabilityAneuploidyAnimalsChromosome SegregationDNA DamageEmbryonic DevelopmentFemaleGene Expression Regulation, DevelopmentalMaleMiceCdc25a protein, mousecdc25 PhosphatasesCDC2 Protein KinaseCdk1 protein, mouseCheckpoint Kinase 1Chek1 protein, mouseCDC25A phosphataseCDK1 kinasecell cycle regulationCHK1 kinaseearly mouse embryos

Identifiers

PMID37694680
PMCPMC10561370
OpenAlexW4386592675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.